市場調查報告書

抗真菌藥物市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年

Antifungal Drugs Market, by Drug Type, By Indication, By Dosage Form, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 968739
出版日期 內容資訊 英文 149 Pages
商品交期: 2-3個工作天內
價格
抗真菌藥物市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年 Antifungal Drugs Market, by Drug Type, By Indication, By Dosage Form, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年09月24日內容資訊: 英文 149 Pages
簡介

抗真菌藥用於治療真菌感染。OTC藥物的日益普及有望在不久的將來推動抗真菌藥物市場的增長。OTC藥物對患者而言具有成本效益,而針對皮膚感染的抗真菌藥物的推廣正在推動市場增長。

本報告提供全球抗真菌藥物市場相關調查分析,提供市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 調查目的與前提條件

第2章 市場範圍

第3章 市場動態·規定·趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 市場趨勢
  • 主要的發展
  • 影響分析
  • M&A
  • 新產品銷售
  • 技術概要
  • PEST分析

第4章 全球抗真菌藥物市場:COVID-19的影響分析

  • COVID-19的影響分析
  • 新開發

第5章 全球抗真菌藥物市場:各藥物類型

  • 簡介
  • Echinocandins
  • Polyenes
  • 丙烯基胺
  • Azole
  • 其他

第6章 全球抗真菌藥物市場:各適應症

  • 簡介
  • 麴菌症
  • 皮膚絲狀菌症 (癬)
  • 念珠菌症
  • 其他

第7章 全球抗真菌藥物市場:各劑型

  • 簡介
  • 粉末
  • 軟膏
  • 藥物
  • 其他

第8章 全球抗真菌藥物市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第9章 競爭情形

  • 企業簡介
    • GlaxoSmithKline Plc
    • Bayer AG
    • Abbott Laboratories
    • Merck & Co., Inc
    • Glenmark Pharmaceuticals Limited
    • Enzon Pharmaceuticals, Inc.
    • Pfizer Inc.
    • Gilead Sciences, Inc.
    • Sanofi SA
    • Astellas Pharma, Inc.

第10章 章節

目錄

Title:
Antifungal Drugs Market, by Drug Type (Echinocandins, Polyenes, Allylamines, Azoles, and Others), By Indication (Aspergillosis, Dermatophytosis, Candidiasis, and Others), By Dosage Form (Powders, Ointments, Drugs, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Anti-fungal drugs are used to treat fungal infections. Common fungal infections such as fungal nail infection, vaginal infection, and ringworm usually occur on the external surface of the body, while certain fungal invasive infections occur inside the tissue of body or in an internal organ such as lungs and brain. Fungal infection is usually associated with a weak immune system, such as people suffering from HIV and AIDS, and those undergoing high dosage chemotherapy who are more susceptible to invasive fungal infections. Anti-fungal drugs work against fungal infections by either killing the fungal cells or by inhibiting their growth. Anti-fungal drugs are broadly classified as topical antifungals, oral antifungals, intravenous antifungals, and intravaginal antifungal pessaries.

As per stats released by the Centers for Disease Control and Prevention (CDC), around 1 million people worldwide get infected by cryptococcal meningitis, which is a brain infection caused by fungus Cryptococcus and it subsequently leads to 625,000 deaths. These cases are mainly reported in sub-Saharan Africa. Also, the histoplasmosis infection mostly occurs in the U.S. and some portions of Central and South America. As per CDC's study, histoplasmosis is a common infection observed in people with HIV and AIDS. In case of histoplasmosis, late diagnosis and treatment can be fatal.

Market Dynamics

The growing popularity of OTC drugs is expected to drive growth of the antifungal drugs market in near the future. OTC drugs are cost effective for patients and advertisement and promotion of antifungal drugs for dermal infections such as skin infections are favouring the growth of the market.

Furthermore, major players in the market are focused on various growth strategies such as collaborations and agreements in order to enhance their market presence. For instance, in June 2017, Basilea Pharmaceutica Ltd., a biopharmaceutical company, entered an agreement with Pfizer, Inc. and Avir Pharma, Inc. for the distribution of Beasilea's antifungal treatments. Pfizer will manufacture and distribute drugs for treatment of life-threatening invasive mold infections in Russia, Israel, Europe (excluding Nordics), and Turkey.

Similarly, key players in the market are focused on various business strategies such as research and development in order to expand their product portfolio. Increasing drug development is expected to drive grow of this market. For instance, in January 2019, SCYNEXIS, Inc., a biotechnology company, announced positive interim result from first interim efficiency analysis of an ongoing FURI study. The development of this novel treatment is indicated for fungal treatment.

Key features of the study:

  • This report provides in-depth analysis of the global antifungal drugs market, market size (US$ mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players.
  • It profiles key players in the global antifungal drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study are GlaxoSmithKline Plc, Bayer AG, Abbott Laboratories, Merck & Co., Inc, Glenmark Pharmaceuticals Limited, Enzon Pharmaceuticals, Inc., Pfizer Inc., Gilead Sciences, Inc., Sanofi S.A. and Astellas Pharma, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global antifungal drugs market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers of Infertility drugs and devices, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Antifungal Drugs Market, By Drug Type:
    • Echinocandins
    • Polyenes
    • Allylamines
    • Azoles
    • Others
  • Global Antifungal Drugs Market, By Indication:
    • Aspergillosis
    • Dermatophytosis
    • Candidiasis
    • Others
  • Global Antifungal Drugs Market, By Dosage Form:
    • Powders
    • Ointments
    • Drugs
    • Others
  • Global Antifungal Drugs Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Drug Type:
    • Echinocandins
    • Polyenes
    • Allylamines
    • Azoles
    • Others
      • By Indication:
    • Aspergillosis
    • Dermatophytosis
    • Candidiasis
    • Others
      • Dosage Form:
    • Powders
    • Ointments
    • Drugs
    • Others
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Drug Type:
    • Echinocandins
    • Polyenes
    • Allylamines
    • Azoles
    • Others
      • By Indication:
    • Aspergillosis
    • Dermatophytosis
    • Candidiasis
    • Others
      • Dosage Form:
    • Powders
    • Ointments
    • Drugs
    • Others
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Drug Type:
    • Echinocandins
    • Polyenes
    • Allylamines
    • Azoles
    • Others
      • By Indication:
    • Aspergillosis
    • Dermatophytosis
    • Candidiasis
    • Others
      • Dosage Form:
    • Powders
    • Ointments
    • Drugs
    • Others
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Drug Type:
    • Echinocandins
    • Polyenes
    • Allylamines
    • Azoles
    • Others
      • By Indication:
    • Aspergillosis
    • Dermatophytosis
    • Candidiasis
    • Others
      • Dosage Form:
    • Powders
    • Ointments
    • Drugs
    • Others
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
      • By Drug Type:
    • Echinocandins
    • Polyenes
    • Allylamines
    • Azoles
    • Others
      • By Indication:
    • Aspergillosis
    • Dermatophytosis
    • Candidiasis
    • Others
      • Dosage Form:
    • Powders
    • Ointments
    • Drugs
    • Others
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
      • By Drug Type:
    • Echinocandins
    • Polyenes
    • Allylamines
    • Azoles
    • Others
      • By Indication:
    • Aspergillosis
    • Dermatophytosis
    • Candidiasis
    • Others
      • Dosage Form:
    • Powders
    • Ointments
    • Drugs
    • Others
    • Company Profiles
      • GlaxoSmithKline Plc*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
      • Bayer AG
      • Abbott Laboratories
      • Merck & Co., Inc
      • Glenmark Pharmaceuticals Limited
      • Enzon Pharmaceuticals, Inc.
      • Pfizer Inc.
      • Gilead Sciences, Inc.
      • Sanofi S.A.
      • Astellas Pharma, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snapshot, By Indication
    • Market Snapshot, By Dosage Form
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Market Trends
  • Key Developments
  • Impact Analysis
  • Mergers & Acquisitions
  • New Product Launch
  • Technology Overview
  • PEST Analysis

4. Global Antifungal Drugs Market, by COVID-19 Impact Analysis

  • COVID 19 Impact Analysis
  • New Developments

5. Global Antifungal Drugs Market, By Drug Type, 2016 - 2027, (US$ million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Echinocandins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Polyenes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Allylamines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Azoles
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. Global Antifungal Drugs Market, By Indication, 2016 - 2027, (US$ million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Aspergillosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Dermatophytosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Candidiasis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Antifungal Drugs Market, By Dosage Form, 2016 - 2027, (US$ million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Powders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Ointments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

8. Global Antifungal Drugs Market, By Region, 2016- 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, By Drug Type, 2020 and 2027 (%)
    • Market Share Analysis, By Indication, 2020 and 2027 (%)
    • Market Share Analysis, By Dosage Form, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2027
    • Regional Trends
  • North America
    • Market Share Analysis, By Drug Type, 2020 and 2027 (%)
    • Market Share Analysis, By Indication, 2020 and 2027 (%)
    • Market Share Analysis, By Dosage Form, 2020 and 2027 (%)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Share Analysis, By Drug Type, 2020 and 2027 (%)
    • Market Share Analysis, By Indication, 2020 and 2027 (%)
    • Market Share Analysis, By Dosage Form, 2020 and 2027 (%)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Share Analysis, By Drug Type, 2020 and 2027 (%)
    • Market Share Analysis, By Indication, 2020 and 2027 (%)
    • Market Share Analysis, By Dosage Form, 2020 and 2027 (%)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Share Analysis, By Drug Type, 2020 and 2027 (%)
    • Market Share Analysis, By Indication, 2020 and 2027 (%)
    • Market Share Analysis, By Dosage Form, 2020 and 2027 (%)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Share Analysis, By Drug Type, 2020 and 2027 (%)
    • Market Share Analysis, By Indication, 2020 and 2027 (%)
    • Market Share Analysis, By Dosage Form, 2020 and 2027 (%)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Share Analysis, By Drug Type, 2020 and 2027 (%)
    • Market Share Analysis, By Dosage Form, 2020 and 2027 (%)
    • Market Share Analysis, By Indication, 2020 and 2027 (%)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East

9. Competitive Landscape

  • Company Profiles
    • GlaxoSmithKline Plc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Bayer AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Merck & Co., Inc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Glenmark Pharmaceuticals Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Enzon Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Gilead Sciences, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Sanofi S.A.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Astellas Pharma, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

10. Section

  • References
  • Research Methodology
  • About Us and Sales Contact